$VTGN News Article - Positive Pilot Phase 3 Data Position VistaGen's PH94B Neuroactive Nasal Spray for Pivotal Phase 3 Development as a Novel, As-Needed Treatment for Social Anxiety Disorder https://marketwirenews.com/news-releases/posi...23336.html
(0)
(0)
VistaGen Therapeutics, Inc. (VTGN) Stock Research Links